STORY Closed Or Open, No Easy Answers Anywhere For Schools
February 3, 2021
STORY Novavax Vaccine Delivers 89% Efficacy Against COVID-19 in UK—But Is Less Potent in South Africa
January 29, 2021
STORY School Risk Calculations Scrambled by Fast-Spreading Virus Strains
January 19, 2021
STORY Could Too Much Time Between Doses Drive the Coronavirus To Outwit Vaccines?
January 14, 2021
STORY Debates Intensify Over Dosing Plans for Authorized COVID-19 Vaccines
January 7, 2021
STORY Viral Mutations May Cause Another ‘Very, Very Bad’ COVID-19 Wave, Scientists Warn
January 6, 2021
STORY ‘It’s Crazy.’ Upbeat COVID-19 Vaccine News From China and U.K. Leaves Scientists Wanting More Details
December 31, 2020
STORY U.K. Variant Puts Spotlight on Immunocompromised Patients’ Role in the COVID-19 Pandemic
December 24, 2020
STORY Mutant Coronavirus in the United Kingdom Sets off Alarms, but Its Importance Remains Unclear
December 21, 2020
STORY As COVID-19 Vaccines Emerge, a Global Waiting Game Begins
December 16, 2020
STORY After Dosing Mix-Up, Latest COVID-19 Vaccine Success Comes With Big Question Mark
November 30, 2020
STORY Another COVID-19 Vaccine Success? Candidate May Prevent Further Coronavirus Transmission, Too
November 23, 2020
STORY Worlds Collide When Three Science Reporters—and Parents—Cover Coronavirus and Schools
STORY Should Researchers Shelve Plans to Deliberately Infect People With the Coronavirus?
STORY German Kids Went Back in School. Missouri Parents Whose Kids Are Still at Home Fear a Lost Year
November 3, 2020
STORY What Missouri Schools Can Learn From How Germany Has Handled School Reopenings
November 2, 2020
STORY The ‘Very, Very Bad Look’ of Remdesivir, the First FDA-Approved COVID-19 Drug
October 29, 2020
STORY How German Students Have Been Back At School Since Spring, While Missourians Are Just Returning
October 21, 2020